- ConsumersSupporters may cite increased availability of lower‑cost short‑term insurance plan options for some consumers.
- Federal agenciesIt would reduce federal regulatory requirements on insurers offering short‑term and excepted benefit products.
- Potential benefitInsurers and brokers could face fewer compliance burdens, possibly lowering administrative costs.
Healthcare Freedom and Choice Act
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by t…
The bill, titled the Healthcare Freedom and Choice Act, declares that the interagency final rule published at 89 Fed. Reg. 23338 (April 3, 2024) by the IRS, Employee Benefits Security Administration, and HHS concerning short-term limited-duration insurance and independent, noncoordinated excepted benefits coverage shall have no force or effect.
Choice and affordability versus comprehensive consumer protections
Relative to its intended legislative type, this bill is narrowly and unambiguously drafted to eliminate a single named final interagency rule, but it provides little accompanying detail on implementation, interaction with existing law, fiscal impact, transitions, or oversight.
The bill, titled the Healthcare Freedom and Choice Act, declares that the interagency final rule published at 89 Fed.
Reg. 23338 (April 3, 2024) by the IRS, Employee Benefits Security Administration, and HHS concerning short-term limited-duration insurance and independent, noncoordinated excepted benefits coverage shall have no force or effect.
In short, it nullifies that specific April 3, 2024 regulatory rule.
Narrow deregulatory intent aids passage in a sympathetic chamber, but contested subject matter and higher Senate thresholds reduce overall odds.
Relative to its intended legislative type, this bill is narrowly and unambiguously drafted to eliminate a single named final interagency rule, but it provides little accompanying detail on implementation, interaction with existing law, fiscal impact, transitions, or oversight.
Choice and affordability versus comprehensive consumer protections
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- ConsumersCritics may argue it weakens consumer protections by allowing more limited plans that exclude comprehensive benefits.
- Potential burdenIt could increase risk of adverse selection, raising premiums in ACA‑compliant individual markets.
- ConsumersMore consumers could face coverage gaps or unexpected out‑of‑pocket costs due to limited plan benefits.
Why the argument around this bill splits.
Choice and affordability versus comprehensive consumer protections
Likely opposed.
They would view nullifying the rule as rolling back consumer protections and reopening pathways to non-ACA plans that can exclude benefits.
They expect increased marketplace risk segmentation and harm to people needing comprehensive coverage.
Cautious/mixed.
Appreciates consumer choice and temporary affordability, but worried about adverse selection and consumer confusion.
Would favor targeted guardrails and transparency measures rather than wholesale nullification without safeguards.
Likely supportive.
Views nullification as reducing federal overreach, restoring market choice, and improving short-term affordability.
Prefers state flexibility and private-market solutions over the challenged federal rule.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow deregulatory intent aids passage in a sympathetic chamber, but contested subject matter and higher Senate thresholds reduce overall odds.
- No CBO score or quantified market impact included
- Unknown level of bipartisan support in each chamber
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Choice and affordability versus comprehensive consumer protections
Narrow deregulatory intent aids passage in a sympathetic chamber, but contested subject matter and higher Senate thresholds reduce overall…
Relative to its intended legislative type, this bill is narrowly and unambiguously drafted to eliminate a single named final interagency rule, but it provides little accompanying detail on implementation, interaction wi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.